These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 404419)
21. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs. Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279 [TBL] [Abstract][Full Text] [Related]
22. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics. Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720 [TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of the effect of probenecid on pharmacokinetics of 99mTc-mercaptoacetyltriglycine in dogs. Kakizaki T; Yokoyama Y; Natsuhori M; Yamada N; Hashimoto M; Sato K; Ito N; Daniel GB J Vet Pharmacol Ther; 2005 Dec; 28(6):559-64. PubMed ID: 16343289 [TBL] [Abstract][Full Text] [Related]
24. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans. Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130 [TBL] [Abstract][Full Text] [Related]
25. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats. Hu J; Liu X; Xie L; Wang G; Liu H Xenobiotica; 2007 Jun; 37(6):579-91. PubMed ID: 17614005 [TBL] [Abstract][Full Text] [Related]
26. Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys. Cayen MN; Hicks DR; Ferdinandi ES; Kraml M; Greselin E; Dvornik D Drug Metab Dispos; 1985; 13(4):412-9. PubMed ID: 2863103 [TBL] [Abstract][Full Text] [Related]
27. Dramatic increase in hepatic and biliary curcumin exposure by modulation of its elimination pathway in rats. Lee JH; Kim HG; Oh JH; Lee YJ J Pharm Pharmacol; 2013 Mar; 65(3):423-9. PubMed ID: 23356851 [TBL] [Abstract][Full Text] [Related]
28. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. Yasui-Furukori N; Uno T; Sugawara K; Tateishi T Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527 [TBL] [Abstract][Full Text] [Related]
29. Clearance of furosemide by the gastrointestinal tract. Valentine JF; Brater DC; Krejs GJ J Pharmacol Exp Ther; 1986 Jan; 236(1):177-80. PubMed ID: 3941391 [TBL] [Abstract][Full Text] [Related]
30. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777 [TBL] [Abstract][Full Text] [Related]
31. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947 [TBL] [Abstract][Full Text] [Related]
32. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats. Aiba T; Sakurai Y; Tsukada S; Koizumi T J Pharmacol Exp Ther; 1995 Jan; 272(1):94-9. PubMed ID: 7815370 [TBL] [Abstract][Full Text] [Related]
33. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans. Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetics of pramiverine in rats, dogs, and monkeys (author's transl)]. Steiner K; Diekmann HW; Garbe A; Nowak H Arzneimittelforschung; 1976 Apr; 26(4b):717-21. PubMed ID: 821494 [TBL] [Abstract][Full Text] [Related]
35. Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence. Lin JH; Chiba M; Chen IW; Nishime JA; Vastag KJ Drug Metab Dispos; 1996 Dec; 24(12):1298-306. PubMed ID: 8971134 [TBL] [Abstract][Full Text] [Related]
36. Probenecid inhibits the glucuronidation of indomethacin and O-desmethylindomethacin in humans. A pilot experiment. Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP; van Ewijk-Beneken Kolmer EW Pharm World Sci; 1994 Feb; 16(1):22-6. PubMed ID: 8156046 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of renal tubular transport of methotrexate by probenecid. Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785 [TBL] [Abstract][Full Text] [Related]
38. Effect of probenecid on the dose-response relationship of bumetanide at steady state. Lau HS; Shih LJ; Smith DE J Pharmacol Exp Ther; 1983 Oct; 227(1):51-4. PubMed ID: 6620171 [TBL] [Abstract][Full Text] [Related]
39. Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretion. Zamboni WC; Houghton PJ; Johnson RK; Hulstein JL; Crom WR; Cheshire PJ; Hanna SK; Richmond LB; Luo X; Stewart CF J Pharmacol Exp Ther; 1998 Jan; 284(1):89-94. PubMed ID: 9435165 [TBL] [Abstract][Full Text] [Related]
40. The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study. Baber N; Halliday L; Sibeon R; Littler T; Orme ML Clin Pharmacol Ther; 1978 Sep; 24(3):298-307. PubMed ID: 688724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]